Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anukana Bhattacharjee

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Biorxiv : the Preprint Server for Biology|March 22, 2023
Quantifying tumor specificity using Bayesian probabilistic modeling for drug target discovery and prioritizationGuangyuan Li, Anukana Bhattacharjee, Nathan Salomonis
Nucleic Acids Research|October 18, 2017
Dynamic DNA binding, junction recognition and G4 melting activity underlie the telomeric and genome-wide roles of human CSTAnukana Bhattacharjee, Yongyao Wang, Jiajie Diao, et al.
Plos Genetics|October 1, 2016
STN1 OB Fold Mutation Alters DNA Binding and Affects Selective Aspects of CST FunctionAnukana Bhattacharjee, Jason Stewart, Mary Chaiken, et al.
Cell Reports Methods|November 8, 2024
Quantifying tumor specificity using Bayesian probabilistic modeling for drug and immunotherapeutic target discoveryGuangyuan Li, Daniel Schnell, Anukana Bhattacharjee, et al.
Nature Communications|July 21, 2018
CTC1-STN1 terminates telomerase while STN1-TEN1 enables C-strand synthesis during telomere replication in colon cancer cellsXuyang Feng, Shih-Jui Hsu, Anukana Bhattacharjee, et al.
Journal of Translational Medicine|August 13, 2024
miR-876-3p is a tumor suppressor on 9p21 that is inactivated in melanoma and targets ERKVladimir Bezrookove, Imran Khan, Anukana Bhattacharjee, et al.
Nucleic Acids Research|April 6, 2023
CTC1 OB-B interaction with TPP1 terminates telomerase and prevents telomere overextensionHuan Wang, Tengfei Ma, Xiaotong Zhang, et al.
Science Translational Medicine|January 17, 2024
Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapyGuangyuan Li, Shweta Mahajan, Siyuan Ma, et al.
Blood|November 8, 2022
Retinoid X receptor promotes hematopoietic stem cell fitness and quiescence and preserves hematopoietic homeostasisMaría Piedad Menéndez-Gutiérrez, Jesús Porcuna, Ramesh Nayak, et al.
The Journal of Clinical Investigation|July 10, 2025
Combinatorial therapy regimens targeting preclinical models of melanoma resistant to immune checkpoint blockadeImran Khan, Aida Rodriguez-Brotons, Anukana Bhattacharjee, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biorxiv : the Preprint Server for Biology|March 22, 2023
Quantifying tumor specificity using Bayesian probabilistic modeling for drug target discovery and prioritizationGuangyuan Li, Anukana Bhattacharjee, Nathan Salomonis
Nucleic Acids Research|October 18, 2017
Dynamic DNA binding, junction recognition and G4 melting activity underlie the telomeric and genome-wide roles of human CSTAnukana Bhattacharjee, Yongyao Wang, Jiajie Diao, et al.
Plos Genetics|October 1, 2016
STN1 OB Fold Mutation Alters DNA Binding and Affects Selective Aspects of CST FunctionAnukana Bhattacharjee, Jason Stewart, Mary Chaiken, et al.
Cell Reports Methods|November 8, 2024
Quantifying tumor specificity using Bayesian probabilistic modeling for drug and immunotherapeutic target discoveryGuangyuan Li, Daniel Schnell, Anukana Bhattacharjee, et al.
Nature Communications|July 21, 2018
CTC1-STN1 terminates telomerase while STN1-TEN1 enables C-strand synthesis during telomere replication in colon cancer cellsXuyang Feng, Shih-Jui Hsu, Anukana Bhattacharjee, et al.
Journal of Translational Medicine|August 13, 2024
miR-876-3p is a tumor suppressor on 9p21 that is inactivated in melanoma and targets ERKVladimir Bezrookove, Imran Khan, Anukana Bhattacharjee, et al.
Nucleic Acids Research|April 6, 2023
CTC1 OB-B interaction with TPP1 terminates telomerase and prevents telomere overextensionHuan Wang, Tengfei Ma, Xiaotong Zhang, et al.
Science Translational Medicine|January 17, 2024
Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapyGuangyuan Li, Shweta Mahajan, Siyuan Ma, et al.
Blood|November 8, 2022
Retinoid X receptor promotes hematopoietic stem cell fitness and quiescence and preserves hematopoietic homeostasisMaría Piedad Menéndez-Gutiérrez, Jesús Porcuna, Ramesh Nayak, et al.
The Journal of Clinical Investigation|July 10, 2025
Combinatorial therapy regimens targeting preclinical models of melanoma resistant to immune checkpoint blockadeImran Khan, Aida Rodriguez-Brotons, Anukana Bhattacharjee, et al.
Pageof 2